Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 16,200 shares at $64.18 ($1.0M) on 2023-03-20, disclosed to the SEC on 2023-03-21.
Open-market sale of $1.0M NARI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.18 | 7,200 | $462K | 44.4% |
| 2 | $64.18 | 7,200 | $462K | 44.4% |
| 3 | $64.73 | 1,800 | $117K | 11.2% |
| Total | $64.24 avg | 16,200 | $1.0M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |